Hydroxyurea vs placeboHealth status and quality of life · people with sickle cell disease1 finding from 1 reviewHydroxyurea (hydroxycarbamide) for sickle cell disease 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 277 participantsLow